[Clinical and pathological features and prognostic analysis of early-onset intrahepatic cholangiocarcinoma].
Dongjun Qin(XinHua Hospital), Z W Quan(XinHua Hospital), Zhimin Geng(Children's Hospital of Zhejiang University), Wenlong Zhai(Zhengzhou University), Hong Wu(Sichuan University), Rongruo Lin(Jilin University), Yinghe Qiu(Second Military Medical University), Xiaoling Liang(Sir Run Run Shaw Hospital), Yu He(Southern University of Science and Technology), Tianqiang Song(Tianjin Medical University Cancer Institute and Hospital), Zhangjun Cheng(Zhongda Hospital Southeast University), C D Sun(Qingdao University), Jing Chen(Zhejiang Institute of Special Equipment Inspection), Zhaohui Tang(Shanxi Agricultural University), Yi Tang(XinHua Hospital), X H Mao(Hunan Provincial People's Hospital), Zhe-Yuan Li(XinHua Hospital), J D Li(GlaxoSmithKline (China)), Donge Tang(Shenzhen Second People's Hospital)
Cited by 0
Related Papers
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
|Molecular Cancer|2022|652
Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents
|Gut|2020|578
Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia
|EBioMedicine|2016|345
Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases
|Proceedings of the National Academy of Sciences|2018|324